Virbac (XPAR:VIRP) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:VIRP Virbac SA XPAR:VIRP
94 GF Score
Price €341.50
GF Value €366.89
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Virbac Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

XPAR:VIRP
94GF Score
Virbac SA XPAR:VIRP
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Virbac (XPAR:VIRP) Overvalued in 2026?

Based on GuruFocus' analysis, Virbac stock appears to be undervalued. The current stock price of €341.50 is trading 6.9% below its estimated GF Value™ of €366.89. GuruFocus considers Virbac to be Fairly Valued.

Key valuation signals for XPAR:VIRP:

  • Dividends Received:
  • GF Value™: €366.89 vs. price of €341.50 (6.9% below fair value)
  • GF Score™: 94/100 with 2 warning signs

No single metric tells the full story. See the XPAR:VIRP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Virbac Business Description

Other Exchanges VRBCF:USA0NM7:UKV16:Germany
Address 13e rue, 1ere avenue 2065, LID - BP 27, Carros, FRA, 06511
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.
94GF Score

Get the complete analysis for XPAR:VIRP

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€341.50
Price
€366.89
GF Value